Variant Synonymizer: Platform to identify mutations defined in different ways is available now!

VarSy

Over 2,000 gene–disease validation summaries are now available—no login required!

Browse Summaries

COQ2 – Multiple System Atrophy

Genetic studies in Japanese multiplex families identified homozygous (M78V-V343A/M78V-V343A) and compound heterozygous (R337X/V343A) COQ2 mutations segregating with MSA in two pedigrees (PMID:23758206). Subsequent East Asian case–control series and a meta-analysis encompassing Japanese, Korean, mainland Chinese, and Taiwanese cohorts demonstrated a significant association of the heterozygous c.1178T>C (p.Val393Ala) susceptibility variant with the cerebellar subtype of MSA (MSA-C; pooled OR 2.12, p = 0.004) (PMID:26590992; PMID:34455210). However, large cohorts from Italy and the United States failed to replicate these findings in Caucasian populations (PMID:31398377; PMID:25373618), and a cosegregation analysis of the c.-23C>G variant did not support pathogenicity (PMID:27394078). Overall, an autosomal recessive inheritance model with incomplete penetrance is proposed but remains unconfirmed.

Functional assays confirm that COQ2 missense and loss-of-function variants impair para-hydroxybenzoate-polyprenyltransferase activity, leading to deficient coenzyme Q10 biosynthesis in patient fibroblasts and yeast complementation models (PMID:16400613; PMID:17374725). CoQ10 levels are significantly reduced in the cerebellum of MSA patients and in plasma of MSA cohorts, supporting a pathogenic mechanism driven by mitochondrial dysfunction and oxidative stress independent of COQ2 genotype (PMID:27235405; PMID:27356913). Despite strong mechanistic plausibility, inconsistent replication across populations and limited segregation data yield a Limited classification. COQ2 genotyping in MSA-C patients may inform risk stratification and highlight potential benefit from CoQ10 supplementation.

References

  • The New England Journal of Medicine • 2013 • Mutations in COQ2 in familial and sporadic multiple-system atrophy PMID:23758206
  • Neurological Sciences • 2016 • Association of the COQ2 V393A variant with risk of multiple system atrophy in East Asians: a case-control study and meta-analysis of the literature PMID:26590992
  • Journal of the Neurological Sciences • 2021 • COQ2 V393A confers high risk susceptibility for multiple system atrophy in East Asian population PMID:34455210
  • Gene • 2019 • Genetic mutation analysis of the COQ2 gene in Italian patients with multiple system atrophy PMID:31398377
  • Molecular Neurodegeneration • 2014 • Analysis of COQ2 gene in multiple system atrophy PMID:25373618
  • Neurobiology of Aging • 2016 • Mutational analysis of COQ2 in patients with MSA in Italy PMID:27394078
  • American Journal of Human Genetics • 2006 • A mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency PMID:16400613
  • Human Molecular Genetics • 2007 • Missense mutation of the COQ2 gene causes defects of bioenergetics and de novo pyrimidine synthesis PMID:17374725
  • Journal of Neuropathology & Experimental Neurology • 2016 • Decreased Coenzyme Q10 Levels in Multiple System Atrophy Cerebellum PMID:27235405
  • JAMA Neurology • 2016 • Plasma Coenzyme Q10 Levels in Patients With Multiple System Atrophy PMID:27356913

Evidence Based Scoring (AI generated)

Gene–Disease Association

Limited

Recessive COQ2 mutations segregating in two Japanese families and heterozygous susceptibility variant in East Asian cohorts, but lacking consistent replication and insufficient segregation.

Genetic Evidence

Limited

Recessive mutations in 2 families and association studies in ~500 East Asian cases, but negative replication in Caucasian cohorts.

Functional Evidence

Moderate

Cellular and yeast assays demonstrate impaired COQ2 activity and CoQ10 biosynthesis; reduced CoQ10 levels observed in MSA patient tissues.